The Psychopharmacologists 3 completes a trio of interview-based books about the process of therapeutic innovation in clinical psychiatry. David Healy's method is to interview key individuals involved in the discovery and deployment of drugs that have proved useful to psychiatry, and to draw them together within a model of the mechanism and clinical discovery that he uses as an overall framework. These are historical accounts but highly relevant to the clinical psychiatrist of today, emphasising the importance of research, and of the marketing strategies of pharmaceutical companies in formulating disease entities as well as treatments for them.

The Psychopharmacologists 3 completes a trio of interview-based books about the process of therapeutic innovation in clinical psychiatry. David Healy's method is to interview key individuals involved in the discovery and deployment of drugs that have proved useful to psychiatry, and to draw them together within a model of the mechanism and clinical discovery that he uses as an overall framework. These are historical accounts but highly relevant to the clinical psychiatrist of today, emphasising the importance of research, and of the marketing strategies of pharmaceutical companies in formulating disease entities as well as treatments for them.

Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. It includes digital tools offering instant access to additional information on psychotropic medications. TOPICS INCLUDE Conceptual framework for prescribing psychotropics Newly approved medications, changes in regulations and guidelines, and updates in the professional literature are included in this new edition Medications for specific diagnoses--ADHD, anxiety, and depression Food and Drug Administration approved antipsychotics and mood stabilizers and all other medications What to do when treatment is unsuccessful

This third edition of Essentials of Psychopharmacology is, like its predecessors, based on the premier textbook in the field, The American Psychiatric Publishing Textbook of Psychopharmacology, now in its fourth edition. The Essentials format is designed to deliver core knowledge to the busy trainee or practitioner in a succinct and accessible manner. Essentials of Psychopharmacology provides a complete overview of clinically focused pharmacotherapeutic principles of vital interest to psychiatry residents, primary care physicians, and other health care professionals. Updated with the latest research findings since the publishing of the fourth edition, Essentials features new chapters on recently introduced medications and updated chapters on others. The book is divided into two parts: Classes of Psychiatric Treatments, which systematically reviews psychotropic medications within each drug class (e.g., antidepressants and anxiolytics, antipsychotics), and Psychopharmacological Treatment, which outlines current pharmacotherapeutic approaches in the major psychiatric disorders as well as in specific patient populations. Although the latter part has been streamlined in this new edition, coverage of critical information such as approved indications, drug interactions, side effects, and other prescribing factors remains comprehensive. Clinicians seeking a reliable reference and guide to the core knowledge base and practice of clinical psychopharmacology can do no better than this new edition of Essentials of Psychopharmacology.

Here is a broad overview of the central topics and issues in psychopharmacology, biological psychiatry and behavioral neurosciences, with information about developments in the field, including novel drugs and technologies. The more than 2000 entries are written by leading experts in pharmacology and psychiatry and comprise in-depth essays, illustrated with full-color figures, and are presented in a lucid style.

The Psychopharmacology Treatment Planner provides all theelements necessary to quickly and easily develop formal treatmentplans that satisfy the demands of HMOs, managed care companies,third-party payors, and state and federal review agencies. * Saves you hours of time-consuming paperwork, yet offers thefreedom to develop customized treatment plans for clients whosetherapy includes psychotropic drugs * Organized around 28 main presenting problems regularly treatedwith a combination of psychotropic and psychotherapeuticinterventions or treatment modalities, from ADHD, dementia, andsubstance abuse to antisocial behavior, bipolar disorders, andmore * Over 1,000 well-crafted, clear statements describe thebehavioral manifestations of each relational problem, long-termgoals, short-term objectives, and clinically tested treatmentoptions * Easy-to-use reference format helps locate treatment plancomponents by behavioral problem or DSM-IV-TR(TM) diagnosis * Includes a sample treatment plan that conforms to therequirements of most third-party payors and accrediting agencies(including HCFA, JCAHO, and NCQA)

Chapters covering depression and bipolar disorder have been revised and expanded by Dr Stephen M. Stahl for this third edition.